Biocryst Pharmaceuticals‘ once-daily oral therapy Orladeyo (berotralstat) is now approved in Japan to prevent swelling attacks in children…
Articles by Marisa Horak, MS
Onvuzosiran, an experimental treatment for hereditary angioedema (HAE) now in Phase 3 testing, has been granted fast track designation…
People with hereditary angioedema (HAE) often have misgivings about the long-term safety and feasibility of preventive treatments, so it’s…
It wasn’t until nearly a decade after she first started experiencing symptoms that a woman in China was diagnosed with…
A woman in her 80s who had taken the same blood pressure medication for 11 years without issue suddenly developed…
More than a third of adults with hereditary angioedema (HAE) were found to have substantial difficulty recognizing their own…
For people with hereditary angioedema (HAE), regardless of a person’s racial or ethnic background, living with this chronic disease…
People with type 3 hereditary angioedema (HAE) may report more frequent swelling attacks than people with HAE types 1…
The case of a new mother who developed severe acute allergic angioedema triggered by a common antibiotic was described…
Dawnzera (donidalorsen), an injection therapy used to reduce the risk of swelling attacks in people with hereditary angioedema…